John Philip Sherrod, MD

Article

What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?

Author:: John Philip Sherrod, MD

Publish date: November 1, 2001

EVIDENCE-BASED ANSWER: There is good evidence that treatment for primary prevention of CAD decreases risk of major first coronary events and cardio...